Academic Journal
Q1Molecular Diagnosis and Therapy
About Molecular Diagnosis and Therapy
Molecular Diagnosis and Therapy is a scholarly journal published by its listed publisher. SCImago 2025 lists it in Q1, with an SJR of 1.812 and H-index of 76.
Coverage: 2001, 2006-2026. Research categories: Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology (Q1).
Verified field sources
- Journal Impact Factor: 4.4 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2024 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Cancer Genomics and Diagnostics; MicroRNA in disease regulation; Lung Cancer Treatments and Mutations; Pharmacogenetics and Drug Metabolism; Genomics and Rare Diseases; Molecular Biology Techniques and Applications.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
5,090.00 USD; 3,990.00 EUR; 3,190.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Development of Diagnostic Models and Biomarker Identification for Type 1 Leptomeningeal Metastasis in Lung Adenocarcinoma Using Olink: Exploratory Cohort Study with Internal Temporal Validation
Peng Ding, Qiuchi Chen, Yun Li, Yulan Kui et al.
2026-09-28 · DOI: 10.1007/s40291-026-00875-0Population Reference Data in the Molecular Diagnosis of Pathogenic CAPN3 Variants: Contextual Evidence and Interpretive Limits
Meghan H. Carr, Ehab Y. Harahsheh, Shaymaa Shurrab, Bukola A. Olarewaju et al.
2026-09-24 · DOI: 10.1007/s40291-026-00880-3Comparison of Maxwell Kit-Based and NaOH-Based DNA Extraction Incorporated copro-DNA-SjTR1-qPCR Systems: Insights from Detecting Low-Intensity Schistosoma Japonicum Infections
Emmanuel John Tabilin, Catherine A. Gordon, Mario A. Jiz, Eleonor Avenido-Cervantes et al.
2026-09-24 · DOI: 10.1007/s40291-026-00883-0Gadoquatrane: First Approval
Simon Fung
2026-09-24 · DOI: 10.1007/s40291-026-00881-2Orca-T: First Approval
Hannah A. Blair
2026-09-17 · DOI: 10.1007/s40291-026-00882-1Rapid Ex Vivo Visualization of Laryngeal Tumors Using a Sprayable pH-Activatable Fluorophore
Daan G. J. Linders, Sebastiaan W. R. Dalmeijer, Bo E. Zweedijk, Hamed Abbasi et al.
2026-09-11 · DOI: 10.1007/s40291-026-00878-xAmyloid-β PET Radioligands in Alzheimer’s Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring
Simone Lista, Luca Filippi, Enzo Emanuele, Susana López-Ortiz et al.
2026-09-10 · DOI: 10.1007/s40291-026-00879-wBridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2− Metastatic Breast Cancer
Chi-Yin Liao, Jincy John, Precious Anyanwu, Manali A. Bhave et al.
2026-09-08 · DOI: 10.1007/s40291-026-00876-zAnbalcabtagene Autoleucel: First Approval
Arnold Lee
2026-09-07 · DOI: 10.1007/s40291-026-00872-3Integrative Omics of Eosinophils in Asthma and COPD: Deciphering Molecular Signatures for Targeted Therapy
Jun Miyata, Keeya Sunata, Hisashi Sasaki, Shotaro Chubachi et al.
2026-08-22 · DOI: 10.1007/s40291-026-00877-yCirculating MicroRNAs as Diagnostic and Prognostic Biomarkers for Neuroblastoma: A Systematic Review and Exploratory Re-analysis
Kashif Daud, Mubariz Maqsood, Sahill Bajwa, Nicholas Coleman et al.
2026-08-18 · DOI: 10.1007/s40291-026-00873-2Bile Cell-Free DNA as a Tumor-Proximal Source for Molecular Profiling of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Jun-Ha Jang, Gi Yeon Lee, Jung Won Chun, Sang-Jae Park et al.
2026-08-13 · DOI: 10.1007/s40291-026-00870-5Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging
Luca Filippi, Susanna Nuvoli, Angela Spanu, Barbara Palumbo et al.
2026-08-11 · DOI: 10.1007/s40291-026-00871-4Cost-Effectiveness of a Host-Response Point-of-Care Assay for Early Sepsis Diagnosis in UK Emergency Departments
Erika P. Plata-Menchaca, Enrique Hernández-Jiménez, Queralt Caus-Capdevila, Judit Cubedo et al.
2026-08-11 · DOI: 10.1007/s40291-026-00860-7Non-Invasive Prenatal Testing in Donor-Oocyte Pregnancies: Biological Determinants, Algorithmic Limitations and Clinical Implications
Michele Miscia, Irene Pesaresi, Benedetta Dini, Danila Morano et al.
2026-08-08 · DOI: 10.1007/s40291-026-00866-1Unfolded Protein Response Pathways in Cancer: Mechanisms, Tumor Biology and Therapeutic Opportunities
Mercilena Benjamin, Surender Kumar Sharawat, Anita Chopra
2026-08-07 · DOI: 10.1007/s40291-026-00869-yDevelopment of a Point-of-Care Recombinase Polymerase Amplification Assay for Detection of Neisseria gonorrhoeae and Ceftriaxone-Resistance Associated penA Allele 60.001
Xia Sun, Ying Fu, Yi Liu, Qiongyao Liu et al.
2026-09 · DOI: 10.1007/s40291-026-00868-zMultidisciplinary and Personalized Molecular Diagnosis to Solving Sudden Death During Sport
Andrea Costantino, Oscar Campuzano, Fabio Vaiano, Eleonora Nardi et al.
2026-09 · DOI: 10.1007/s40291-026-00867-0Marnetegragene Autotemcel: First Approval
Simon Fung
2026-09 · DOI: 10.1007/s40291-026-00863-4Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies
Bárbara S. Marques, Maria Mendes, José Luís Alves, Alberto Pais et al.
2026-09 · DOI: 10.1007/s40291-026-00864-3Reviews
Community Reviews
Version History
September 25, 2026 at 7:13 am
September 25, 2026